Overview
Acute otitis media (AOM) is an ear infection in which the air-filled space behind the tympanic membrane (middle ear) is infected, causing pain and general illness symptoms such as fever, irritability, and difficulty sleeping. AOM is one of the most common ear infections in children because the eustachian tube is shorter than adults and is more susceptible to bacteria and viruses. Bacteria such as Streptococcus and Hemophilic influenza (H.flu) account for approximately 85% of AOM cases, while viruses account for only 15% of these cases.
Get PDF Brochure with COVID19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-pdf/1333
Drivers
The increase in the prevalence of AOM disease is expected to promote the growth of the global acute otitis media treatment market. According to a study published in the South African Medical Journal in 2014, the global incidence of acute otitis media is 10.9% and it is estimated that 80% of children will have at least one acute otitis media (AOM) before the age of 3 years. Acute otitis media prevalence. The increase is expected to create a favorable environment for the growth of the global acute otitis media treatment market in the near future. In addition, according to a study published in Formulay Journal in 2014, AOM accounts for approximately US$314 in health care expenditures per child per year in the U.S., which is equivalent to an additional US$2.88 billion in health care expenditures. In addition, the strict guidelines and recommendations of various government and non-government agencies on the treatment of children’s AOM are expected to become a growth factor in the market. In 2013, the American Academy of Pediatrics (AAP) updated AOM treatment guidelines. Compared with the previous guidelines issued in 2004, the new guidelines add more criteria for diagnosing AOM. The guideline update is expected to contribute to better diagnosis and higher treatment rates, which may promote the growth of the global acute otitis media treatment market.
The global acute otitis media treatment market was valued at US$1.9439 billion in 2016 and is expected to grow at a CAGR of 5.1% during the forecast period (2017-2025).
The introduction of new products for the treatment of acute otitis media by major players is a factor that is expected to create a favorable environment for market growth in the near future. In 2016, Laboratories SALVAT S.A. and Arbor Pharmaceuticals, LLC launched OTOVEL. This solution is suitable for the treatment of acute otitis media in pediatric patients with a tympanostomy tube (AOMT). Additionally, Otonomy launched OTIPRIO (Ciprofloxacin Ear Suspension) in the U.S. in 2016 for the treatment of pediatric patients with acute bilateral otitis media.
In addition, major players in the production of drugs for the treatment of acute otitis media are working to increase their online business by launching a website to expand their customer base. In 2013, Alcon launched the DROPS101 web tool, a mobile website that provides educational resources on common ear and eye treatments. DROPS101 Web Tools provides product information related to the treatment of acute otitis media. In 2015, Aurobindo Pharma Ltd. was approved by the US FDA to launch its generic drug cefixime in the U.S. market. Cefixime is a third-generation cephalosporin suitable for the treatment of acute otitis media.
Restraints
The price of generic drugs for the treatment of acute otitis media on the market is much lower than that of brand-name drugs, which is the main factor that is expected to hinder growth of the global acute otitis media treatment market in the near future.
Competitive Landscape
Major companies contributing in the global acute otitis media treatment market are Bayer AG, Abbott Laboratories, Eli Lilly and Company, Sanofi S.A., Pfizer, Inc., Bristol Myers Squibb Company, Pediapharm Inc., GlaxoSmithKline plc., and Novartis AG..
Purchase This Premium Report Here With Discounted Price (Flat US $2000 Off) – https://www.coherentmarketinsights.com/promo/buynow/1333
Reasons to Purchase this Report
• Current and future of global Acute Otitis Media Treatment market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837